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ABSTRACT
Schizosaccharomyces pombe is a widely used model organism to
study many aspects of eukaryotic cell physiology. Its popularity as an
experimental system partially stems from the ease of genetic
manipulations, where the innate homology-targeted repair is exploited
to precisely edit the genome. While vectors to incorporate exogenous
sequences into the chromosomes are available, most are poorly
characterized. Here, we show that commonly used fission yeast vectors,
which upon integration produce repetitive genomic regions, give rise to
unstable genomic loci. We overcome this problem by designing a new
series of stable integration vectors (SIVs) that target four different
prototrophy genes. SIVs produce non-repetitive, stable genomic loci
and integrate predominantly as single copy. Additionally, we develop a
set of complementary auxotrophic alleles that preclude false-positive
integration events. We expand the vector series to include antibiotic
resistance markers, promoters, fluorescent tags and terminators, and
build a highly modular toolbox to introduce heterologous sequences.
Finally, as proof of concept, we generate a large set of ready-to-use,
fluorescent probes to mark organelles and cellular processes with a
wide range of applications in fission yeast research.
This article has an associated First Person interview with the first author
of the paper.
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INTRODUCTION
The fission yeast Schizosaccharomyces pombe is a well-established
model organism for studying diverse aspects of cellular biology.
It continues to play a critical role, for instance in the discovery of
fundamental aspects of cell cycle control, chromosome biology,
signalling and cytoskeleton dynamics (Hoffman et al., 2015).
Decades of research have yielded versatile molecular methods to
control the expression of native and foreign genes in this species.
The ability to transform cells with genetic material and create
transgenic lines is critical in biological research. Foreign DNA
fragments are easily delivered to S. pombe cells, where they have
one of two fates. First, circular DNA plasmids can be maintained
as episomal fragments, provided they contain an autonomous
replicating sequence (ARS) (e.g. the pREP series; Craven et al.,
1998; Forsburg and Sherman, 1997; Maundrell, 1993; Moreno
et al., 2000). However, these episomal plasmids do not contain
centromeric segments, because S. pombe centromeres are complex
100 kb-long sequences, distinct from the point centromeres of the
budding yeast S. cerevisiae (Clarke, 1990; Yamagishi et al., 2014).
For this reason, such circular plasmids segregate randomly during
division, leading to variable copy numbers in the population and the
need for continuous selective pressure to prevent plasmid loss.
Second, because homologous recombination is highly efficient,
linear DNA fragments can easily integrate at desired genomic loci.
This allows precise genome editing and direct gene manipulation at
their native locus, the method of choice to alter gene function in
near-physiological conditions. It also allows for integration of
linearized ‘integrative’ plasmids, for instance containing foreign
DNA, to placeholder genomic loci. The most common integrative
vectors typically carry a single homology region. Plasmid
linearization within this region enables homology-directed repair
to target the vector to the desired genomic location (Keeney and
Boeke, 1994; Matsuyama et al., 2004; Maundrell, 1993). However,
this system suffers from the problem that integration leads to
duplication of sequences on either side of the integrated vector
(Siam et al., 2004), which can further recombine and lead to either
amplification or deletion of the integrated fragment. This is
especially noticeable if the insert alters cell fitness, and can cause
reproducibility issues between experiments. A few integrative
plasmids that should not lead to the formation of genomic copies
have been developed, but their stability has not been directly probed
(Fennessy et al., 2014; Kakui et al., 2015).
Here, we present a series of easy-to-use, modular integrative
vectors that insert into the genome as a stable, single copy, without
formation of genomic repeats. The basic elements included in our
vector series are: a bacterial replication origin and ampicillin
resistance (AmpR) sequence, allowing for plasmid amplification in
bacteria, one or two multiple cloning sites (MCS), a sequence
targeting the construct to one of four different chromosomal
locations (ade6, ura4, lys3 or his5), which confers prototrophy post
transformation, and an optional drug resistance marker. We further
expand this basic vector backbone by including various promoter,
fluorescence tag and terminator sequences, allowing for expression
of any gene of interest at desired levels.
The most popular inducible promoter in fission yeast is based on
the strong nmt1 (‘no message in thiamine’) promoter and its two
attenuated versions that carry mutations in the TATA box – namely
nmt41 and nmt81 (Basi et al., 1993; Maundrell, 1990; Maundrell,
1993). The nmt promoters display a strong induction fold after
de-repression (estimated at ∼80-fold for nmt1; Basi et al., 1993), but
their maximal induction time exceeds 15 h and is not completely
synchronous in the population (Maundrell, 1990; Watson et al.,
2013). The urg1 promoter is also inducible and shows a strongReceived 18 October 2019; Accepted 24 November 2019
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induction in the presence of uracil (but also upon nitrogen starvation),
with faster kinetics: maximal transcript levels occur 30 min post
induction and decrease rapidly after uracil removal with both states
being stable for at least 24 h (Watt et al., 2008). However, at non-
native integration sites, the off-state of purg1 is strongly elevated,
reducing the dynamic range of induction (Watson et al., 2013). The
most widely used constitutive promoter is the strong padh1, and a few
others of similar or slightly weaker strength have been described
(Matsuyama et al., 2008; Siam et al., 2004). Here, we make use of the
known inducible promoters (nmt1, nmt41, nmt81, urg1) and a series
of constitutive promoters (cdc12, pom1, rga3, pak1, act1 and tdh1)
that lead to GFP expression over three orders of magnitude.
Our stable integration vector (SIV) series was built in a highly
modular way. For instance, fluorescence tagging vectors allow for
both N- and C-terminal tagging of the construct of interest. As
multicloning sites are identical in all the vectors, quick exchange of
elements allows for further expansion of the toolbox.We demonstrate
the stable and single-copy integration of the SIV series and fully
describe promoter strength. We introduce three new auxotrophic
deletion alleles of the target genomic integration sites (at ade6, lys3
and his5), which abrogate false-positive transformants. Finally, using
the SIV series, we generate a panel of fluorescent bio-markers in three
compatible wavelengths (mTagBFP2, sfGFP or GFP and mCherry),
labelling commonly studied cellular organelles, structures and
processes. We expect these tools to be a valuable asset to all
researchers using the fission yeast system.
RESULTS
The presence of two regions of homology to target
sequences promotes stability of integrants and avoids
tandem integration events
In fission yeast, homologous recombination is efficient and has been
used for decades to introduce exogenous constructs at defined
genomic loci through integration of linearized plasmids. Traditional
integrative vectors contain the wild-type sequence of a prototrophic
selection marker, such as leu1+ or ura4+ in the case of the widely
used pJK148 and pJK210 vectors, respectively. Upon linearization,
plasmids can restore prototrophy upon recombination into
corresponding genomic loci, which in the parental genome carry
inactivating point mutations leading to auxotrophy, such as leu1-32
or ura4-294 (Keeney and Boeke, 1994). While efficient and site-
specific, these recombination events also lead to up to 20% of
transformants with multiple integration events [two or more copies
integrated in tandem in the genome (Keeney and Boeke, 1994)].
Even upon integration of the plasmid in single copy, the procedure
leads to duplication of the auxotrophic marker genomic sequence
(Fig. 1A), which can cause locus instability. Indeed, we observed
that strains in which fluorescent biosensors were introduced on such
integrative vectors occasionally gave rise to cells lacking the probe.
While mutations in the gene encoding the probe could lead to
apparent loss of signal, spontaneous mutations in wild-type fission
yeast are rare (2×10−10 for base substitutions; Farlow et al., 2015)
and thus unlikely to account for the recurrent events we observed
with different probes and strains. Instead, we speculated that the
probe was lost because of recombination between the genomic
repeats created by integrative vectors (Fig. 1A).
To quantify the instability of pJK210 integrants, we introduced a
nourseothricin resistance cassette (natMX) into the pJK210 vector,
which carries a ura4+ gene as a selection marker. We transformed
auxotrophic cells carrying the point mutation ura4-294 and selected
for uracil prototrophswith nourseothricin resistance.We subsequently
cultured these transformants in non-selective medium for 3 days and
plated 1.4×107 cells onto medium containing 5-fluoroorotic acid (5-
FOA), which acts as a counter selection against the ura4+ gene
(Fig. 1C). Inactivation of ura4 in pJK210 integration strains
occurred at a frequency that was three orders of magnitude above
the rates we observed for a wild-type prototroph strain (Fig. 1D,
proportion was 4.1×10−4±1.6×10−4 for pJK210 transformants and
1.4×10−7±2.5×10−7 for wild-type cells, n=6, mean±s.d.).
Furthermore, 58.0±20.3% of transformants with an inactivated
ura4 gene also lost the resistance to nourseothricin, suggesting loss
of vector sequences. Our results suggest that recombination between
the repeats introduced upon pJK210 integration are a likely cause
for the instability of the integrated construct.
We aimed to create an SIV by developing a new pUra4AfeI vector
(Fig. 1B), which integrates at the ura4 locus without creating
genomic repeats. pUra4AfeI linearization at the AfeI site produces two
separate homology regions (Fig. 1B). The first homology arm
contains the functional ura4 cassette [5′ region, open reading frame
(ORF), 3′ region]. The second arm is homologous to sequences just
downstream of the ura4 cassette (3″ region). Integration of the
linearized fragment relies on recombination at both homology
regions, which replaces the genomic ura4 sequences and thus
avoids repeat formation (Fig. 1B). Integration is confirmed using
three diagnostic PCRs, which probe for correct integration on both
sides of the linearized vector and for an increase in the distance
between the 3′ and 3″ ura4 genomic regions (Fig. S1; see Materials
and Methods for details). We introduced the natMX6 cassette using
the pUra4AfeI vector into the ura4-294mutant strain. Nourseothricin-
resistant, uracil prototroph transformants exhibited a stable ura4 locus
with a frequency of cells resistant to 5-FOA similar to that of wild-type
prototrophs (Fig. 1D). Importantly, all of the 5-FOA-resistant clones
that arose in the population maintained the nourseothricin resistance,
indicating continued presence of vector sequence (Fig. 1C). We
conclude that exogenousDNAcan be stably introduced in the genome
at a defined locus by avoiding the formation of genomic repeats.
To monitor the presence or absence of genomic repeats upon
vector integration, we used quantitative PCR (qPCR). We first
characterized the sensitivity of the assay by examining strains
carrying the ura4 gene in single (wild-type ura4+), two ( pak2Δ:
ura4+ ura4+) and three (myo51Δ:ura4+ pak2Δ:ura4+ ura4+)
copies. The qPCR results clearly reflected an increase in ura4 copy
number as compared to the act1 gene, which we used as a reference
locus (Fig. 1E). We then assayed the genomic DNA of 12 clones
obtained by transforming pJK210 and pUra4AfeI vectors. The
majority of pJK210 transformants showed two copies of the ura4
gene, consistent with duplication of the ura4 locus upon vector
integration. In addition, one clone showed a more than 3-fold ura4
signal, revealing a multiple integration event (Fig. 1E), consistent
with previous data showing that pJK210 can integrate in multiple
tandem copies (Keeney and Boeke, 1994). In the case of pUra4AfeI,
all but one clone showed ura4 present in single copy, with one clone
possibly present in two copies (Fig. 1E). Thus, pUra4AfeI integrates
in the genomewithout causing duplication. In addition, these results
show that the majority of transformants result in single-copy
integrations, consistent with the vector design.
To quantify the rates of false-positive clones produced with the
pUra4AfeI vector (e.g. clones that are uracil prototrophs but have not
integrated the vector), we used pUra4AfeI to introduce a locus
encoding high levels of superfolder (sf )GFP into ura4-294 cells.
Blue light illumination showed that transformant colonies obtained
after uracil selection were green due to sfGFP expression. However,
sfGFP expression was absent from 5.2±2.1% (mean±s.d.) of
transformants (Fig. 1F, top panel; Fig. 1G). False-positive
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transformants may arise from a double crossover that only spans the
ura4-294 point mutation and restores the wild-type ura4+ gene
without integrating any vector-specific sequences. The commonly
used ura4-D18 mutant allele (Grimm et al., 1988) has the entire
open reading frame of the ura4 gene deleted, leaving homology
only to the tips of homology arms in the linearized pUra4AfeI
(Fig. 1B). Transformation of pUra4AfeI into cells harboring ura4-
D18 resulted in false-positive rates below the detection limit of our
assay (∼0.2%; Fig. 1F, bottom panel; Fig. 1G). While the routine
transformation protocol still yielded hundreds of transformants, the
Fig. 1. See next page for legend.
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transformation efficiency of pUra4AfeI into the ura4-D18 strains
decreased 3-fold as compared to ura4-294 [Fig. 1H; 1.2±0.3×10−5
and 3.5±1.5×10−5 colony-forming units (CFU)/105 cells for the
ura4 deletion and point mutant, respectively]. We conclude that
restricting homology with the genome to the edges of the linearized
vector leads to decreased rates of false-positive transformants.
Taken together, we show that the pUra4AfeI vector can be used to
reliably integrate sequences in single copy into the genome without
producing genomic repeats. We find that minimal numbers of false-
positive transformants are achieved when targeting the ura4-D18
deletion mutant locus.
A series of SIVs
Experiments increasingly rely on simultaneously monitoring
multiple probes and markers. We thus developed a series of
vectors similar to pUra4AfeI but targeting the additional ade6, lys3
and his5 loci. For each locus, we cloned the plasmid backbone with
one homology arm that contains the 5′ region, ORF and 3′ region,
which is preceded by a linearization site and a second homology
arm targeting the downstream 3″ region (Fig. 2A). We named these
plasmids pAde6PmeI, pLys3BstZ17I and pHis5StuI.
We first tested the stability of pAde6PmeI, pLys3BstZ17I and
pHis5StuI integrants. To this aim, we simultaneously introduced both
ura4+ and antibiotic resistance cassettes into the vectors, linearized
them and transformed them into ura4-D18 uracil auxotroph yeast
cells. Note that these strains were prototroph for adenine, lysine and
histidine. We selected clones that were both uracil prototroph and
antibiotic resistant. We then monitored the stability of the integrated
locus by counter-selecting against ura4+ using 5-FOA. The
inactivation of the ura4 gene occurred at frequencies similar to that
found in wild-type cells (Fig. 2B, proportion of 7.1×10−8±12.4×10−8
for the ade6 locus, 3.3×10−8±5.8×10−8 for the his5 locus, and below
the detection limit for the lys3 locus), suggesting it was due to
spontaneous mutations. Importantly, the strains with an inactivated
ura4 gene invariably maintained the antibiotic resistance (Fig. 2B).
We concluded that, as with pUra4AfeI, transformation with
pAde6PmeI, pLys3BstZ17I and pHis5StuI produces stable integrants.
We note that we also attempted the same strategy to target the leu1
locus with pLeu1StuI but found that the selective marker was rapidly
lost in most transformants after removing the selective pressure.
While we did not pursue this issue further, a possible explanation is
that the leu1 genomic region contains a replication origin, which
allows the plasmid to exist as an unstable, episomal element.
We proceeded to assess the rate of false-positive transformants
with the newly designed vectors. To this aim, we introduced a cassette
that expresses high levels of sfGFP in pAde6PmeI, pLys3BstZ17I and
pHis5StuI and integrated the vectors into the genome of ade6-M210,
lys3-37 or his5Δ1 auxotrophic strains, respectively. After selection for
prototrophs, we could distinguish colonies that do and do not express
the fluorophore, and thus determine the proportion of false positives
(Fig. 2C,D; 8.2±2.6% false positives for ade6-M210, 5.6±1.7% for
lys3-37 and 3.8±2.0% for his5Δ1 alleles, mean±s.d.). We suspected
that we could decrease the false-positive rates by designing new
auxotrophic deletion alleles (detailed in Materials and Methods).
Specifically, we engineered ade6-D19, lys3-D20 and his5-D21
mutants that lack most of the ORF and the immediate 3′ region, and
thus must recombine at both upstream and downstream regions to
introduce the selection marker into the genome. Using these strains to
integrate the fluorescent cassette into the genome almost completely
abolished the appearance of false-positive clones (Fig. 2C,D; 0.21±
0.19% of false positives for ade6-D19, below detection limit for
lys3-D20 and 6.5×10−3±11.3×10−3% for his5-D21 alleles). Using
our new deletion alleles had little effect on overall transformation
efficiencies (Fig. 2E). Finally, we used our plasmids to integrate the
ura4+ cassette at either the ade6, lys3 or his5 locus of the ura4-D18
mutant. This allowed us to then monitor the number of plasmid
integrants by the qPCR assay described above, which compared
relative levels of ura4 and act1 sequences in the genome (Fig. 2F).
We tested 12 transformants with each plasmid and found that all
underwent a single integration event.
Taken together, our results indicate that the pAde6PmeI,
pLys3BstZ17I and pHis5StuI, as well as pUra4AfeI, can be used to
introduce desired sequences into the fission yeast genome almost
without any copy number variation. Furthermore, using auxotrophic
deletion alleles with restricted regions of homology ensures almost
negligible rates of false-positive transformants.
Expanding the usage of the SIVs
Using the above-described vectors requires target strains to be
auxotroph for the required loci. To circumvent this requirement,
we decided to introduce additional dominant selection markers.
We cloned the antibiotic resistance cassettes kanMX6, natMX6,
hphMX6, bleMX6 and bsdMX6 into our vectors (Bähler et al.,
Fig. 1. Two homology arms promote stable vector integration into the
chromosome. (A) Schematic of the pJK210 vector (left panel) and its
integration into the genomic ura4-294 locus post-linearization (right panel). 5′,
ORF and 3′ refer to ura4 gene sequences as indicated in the genomic locus.
AmpR encodes for ampicillin resistance and ori stands for the ColE1 bacterial
replication origin. The unlabelled arrow represents an F1 replication origin. A
single site crossover leads to the integration of the vector and duplication of the
target locus (for detailed explanation see Jasin and Rothstein, 2013; Lee et al.,
2014). (B) Schematic of the pUra4AfeI vector (left panel) and its integration into
the genomic ura4-294 locus post-linearization (right panel). 3″ refers to the
indicated sequences downstream of the 3′ segment. Note that the two
homology regions are separated by the AfeI linearization site. Crossovers at
both homology arms integrate the vector into the genomewithout duplication of
the target locus. Note that the ura4-294 point mutation in the ORF can be
rescued by a single crossover that does not lead to vector integration. The
ura4-D18mutant, which lacks the indicated fragment, only has homology with
the distal ends of the homology arms, ensuring that the vector integrates along
with the ura4+ selection cassette. (C) Assessment of integrant stability. Yeast
strains transformed with the plasmids pJK210 (top) or pUra4AfeI (bottom) in
which the ura4+ and natMX6 selection cassettes were introduced were grown
in non-selective conditions for 3 days and 1.4×107 cells were plated onmedium
with 5-FOA (left panels), which is lethal to cells encoding a functional ura4+
gene. After colonies developed, we replica plated them onto medium
containing nourseothricin (middle panels). False-coloured images from the two
plates are overlaid on the right panel. Note that numerous colonies develop if
selection markers were originally introduced using pJK210 but not pUra4AfeI
vector. Approximately half of the 5-FOA-resistant clones from the pJK210
integration also lost the natMX6 cassette, which was maintained in all clones
obtained from pUra4AfeI-transformed strain. (D) The graph quantifies the
proportion (fraction) of 5-FOA-resistant clones upon plating 1.4×107 cells. The
percentage of cells with nourseothricin resistance is shown at the bottom
of the graph. Statistical significance (pKW) between indicated samples is
reported asP-values from the Kruskal–Wallis test. (E) qPCR results comparing
the relative abundance of act1 and ura4 genomic loci for strains containing the
indicated number of ura4 loci, and for 12 strains obtained by transformation
with indicated plasmids each. (F) Measure of false-positive integrations. The
indicated ura4 mutant alleles were transformed with a cassette for sfGFP
expression cloned into the pUra4AfeI vector and selected for growth onmedium
lacking uracil. The colonies that developed were imaged in white light
(greyscale image) and green fluorescent channel (green) and the images were
overlaid. The arrows point to false-positive colonies that lack the fluorescent
marker but contain the functional ura4 cassette. (G) Quantification of
percentages of false-positive colonies observed in F. (H) Quantification of
overall transformation efficiencies observed in F. TheP-values in G and Hwere
calculated using the paired Student’s t-test. In all graphs, points report
individual data points, bars report average values from multiple replicates and
error bars report standard deviation.
4
TOOLS AND RESOURCES Journal of Cell Science (2020) 133, jcs240754. doi:10.1242/jcs.240754
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Fig. 2. See next page for legend.
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1998; Hentges et al., 2005; Kimura et al., 1994; Sato et al., 2005;
Wach et al., 1994; Table S1 and Fig. 3A; details in Materials and
Methods) in between two MCS to allow for their easy exchange
between vectors. Transformation of linearized vectors into wild-
type strains followed by antibiotic selection readily produced the
desired clones. This set of vectors targeting four distinct genomic
sites with five different dominant selection markers, currently
composed of five distinct vectors (Table S1), can be used to clone
any sequence of interest in either MCS and stably introduce it in the
yeast genome in essentially any yeast strain.
In most experimental settings, control over gene expression levels
is desirable. To this aim, we constructed a second set of vectors, in
which ten different promoters drive the expression of sfGFP
followed by the transcriptional terminator of the budding yeast
CYC1 gene. These include the inducible promoters pnmt1, pnmt41,
pnmt81 and purg1, and six distinct constitutive promoters active
during mitotic growth. MCSs are present in between each of the
fragments to allow their easy exchange, as well as to use the plasmid
for both C- and N-terminal fusion proteins with sfGFP (Fig. 3B,
note that the STOP codon is within the MCS3). Next, we compared
the induction strength of the ten promoters active during mitotic
growth. First, we obtained whole-cell lysates from selected strains
and analysed sfGFP levels by western blotting using tubulin as a
loading control. Both nmt1 and urg1 inducible promoters showed
robust fold differences between non-induced and induced
conditions, with the nmt1 promoter expressing at higher levels
(Fig. 3C). Importantly, we found that the constitutive act1 promoter,
which leads to similar expression levels as the urg1 promoter in
presence of uracil, drives similar expression levels when integrated
at any of the four genomic loci (Fig. 3C). Comparison of sfGFP
expression from the act1 promoter integrated at different genomic
loci by flow cytometry confirmed that the integration site does not
influence expression levels (Fig. 3D). This suggests that there are no
strong differences in chromatin accessibility for transcription
between these four genomic loci, as observed for other loci
(Allshire and Ekwall, 2015), at least in otherwise wild-type cells.
To compare the activity of other promoters driving sfGFP
expression, we quantified the fluorescence detected by spinning disk
confocal microscopy (Fig. 3E; seeMaterials andMethods for details).
As observed by western blotting, the inducible promoters gave a
robust expression increase in induced conditions, with the nmt1
promoter yielding the highest expression level, followed by purg1,
pnmt41 and pnmt81. Note, however that the expression from purg1
increased only ∼20-fold upon uracil addition, as previously reported
(Watson et al., 2013). The tdh1 promoter was the highest-expressing
constitutive promoter, yielding sfGFP expression levels just slightly
lower than the fully induced nmt1 promoter. This is thus a good
promoter for very strong constitutive expression. The act1 promoter
led to about 7-fold lower expression levels, similar to induced urg1.
The pak1, rga3 and pom1 promoters exhibited a further 23-, 27- and
42-fold decrease in levels, respectively. The cdc12 promoter was
about 10-fold weaker, yielding barely detectable GFP levels. Wewere
unable to reliably detect cytosolic sfGFP when expressed from the
repressed nmt81 promoter. However, this is likely due to limitations of
the assay in detecting a weak cytosolic signal against background
organellar fluorescence because we obtained evidence that cdc12 and
nmt81 promoters in the off-state lead to detectable biological activity
(Hachet et al., 2011 and unpublished work by S.G.M. and Iker
Lamas).We further used the act1, pak1, rga3 and pom1 promoters, all
of which lead to detectable levels of cytosolic GFP, to express Ltc1, a
protein localized at ER–PM contact sites (Fig. 3F; Marek et al., 2019
preprint). The localization of Ltc1, which was difficult to detect from
its native promoter, showed a more prominent localization pattern
when mildly overexpressed from pak1, pom1 or rga3 promoters.
Stronger overexpression from the act1 promoter resulted in ectopic
localization throughout the ER. This example illustrates how the range
of promoters driving expression over three orders of magnitude will
allow tweaking of gene expression levels to reveal biological insight.
In summary, we provide three sets of single-integration SIVs:
(1) pUra4AfeI, pAde6PmeI, pLys3BstZ17I and pHis5StuI, which lead to
stable, single-copy integrations when transformed into strains
auxotroph for the corresponding marker gene (Figs 1 and 2); (2) a
derived set containing additional antibiotic resistance cassettes, which
also allow their integration independently of the host strain genotype
in prototrophic strains (Fig. 3A); and (3) a set of vectors with ten
distinct promoters to drive gene expression at defined levels (Fig. 3B).
This third set also needs to be transformed into auxotrophic strains.
However, we note that subcloning with KpnI and SacI restriction
enzymes allows the introduction of a DNA fragment containing
promoter, sfGFP andMCSs from the third plasmid set into the second
set of vectors next to the antibiotic resistance cassette (see section on
‘Recommendations for use of the vectors’ at the end of the Discussion
for guidelines and further examples of modularity). This exemplifies
the modularity of the set of plasmids we created and their possible
expansion.
Using single-copy SIVs to express live-cell biology probes
Synthetic probes are routinely used in cell biology to monitor
molecular dynamics and activity. For reliable quantifications and
phenotype comparisons, it is imperative that probe levels be
comparable between samples. Because our single-integration
vectors show an invariant copy number, we used them to
introduce a number of fluorescent markers into cells (Fig. 4). We
used different loci and antibiotics, which allows to quickly combine
multiple probes in the same cell by genetic crosses. Furthermore, we
used three distinct fluorescent tags, sfGFP (Pédelacq et al., 2006),
mCherry (Snaith et al., 2005) and the blue fluorophore mTagBFP2
(Subach et al., 2011), which produces a signal that is efficiently
Fig. 2. Vector series for stable chromosomal integration. (A) Schematics of
the genomic loci (top) targeted by the pAde6PmeI, pLys3Bstz17I and pHis5StuI
vectors (bottom). The segments that are deleted in the mutants ade6-D19,
lys3-D21 and his5-D21 are also indicated. Notations are as in Fig. 1B.
(B) Assessment of integrant stability. Yeast strains where the ura4 and
antibiotic selection cassettes were introduced on indicated plasmids, were
grown in non-selective conditions for 3 days and plated onto medium with
5-FOA. After colonies developed, we replica plated them onto medium
containing the antibiotic. The graph quantifies the proportion (fraction) of
5-FOA-resistant clones that formed upon plating 1.4×107 cells. The percentage
of antibiotic-resistant colonies is indicated at the bottom. Statistical significance
(pKW) between indicated samples and the wild type is reported as P-values
from the Kruskal–Wallis test. (C) Measure of false-positive integrations.
Indicated mutant alleles were transformed with a cassette for sfGFP
expression cloned into indicated vectors and prototrophs were selected. The
colonies that developed were imaged in white light (greyscale image) and
green fluorescent channel (green) and the images were overlaid. The arrows
point to false-positive prototrophic colonies that lack the fluorescent marker.
(D) Quantification of percentage of false-positive colonies observed in C.
(E) Quantification of overall transformation efficiencies observed in C.P-values
denoted on the top in D and E were calculated for indicated comparisons using
the paired Student’s t-test. (F) Quantitative PCR results comparing relative
abundance of act1 and ura4 genomic loci for strains containing indicated
number of ura4 loci (same data as in Fig. 1E) and for 12 strains obtained by
transformation with indicated plasmids that carry the ura4 gene. Note that all
transformants exhibit ura4/act1 relative levels indicative of a single integration
event. In all graphs, points report individual data points, bars report mean
values from multiple replicates and error bars report standard deviation.
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separated from GFP and mCherry by standard DAPI filters (see
Materials and Methods). We used strong promoters to drive
expression of the cytosolic blue, green and red fluorophore
(Fig. 4A), which can be used to distinguish cells when
simultaneously imaging multiple strains. We also placed the three
fluorophores under mating type-specific promoters that are active
only in P-gametes ( pmap3) or M-gametes ( pmam1*). This allowed us
to clearly differentiate gametes during mating (Fig. 4B; Movie 1).
To visualize the plasma membrane, we fused the three fluorophores
to an amphipathic helix from RitC (Onken et al., 2006; Fig. 4C). We
targeted each fluorophore to the nucleus using a SV40 nuclear
localization sequence at either one (Fig. 4D) or both ends of the
protein (Fig. 4E). To monitor active export of proteins from the
nucleus, we fused sfGFP with the nuclear export sequences from
Alp7 and Wis1 fission yeast proteins (Fig. 4F). To monitor nuclear
envelope integrity, we expressed three copies of mTagBPF2 in
tandem, whose size largely prevents its nuclear influx in wild-type
cells (Fig. 4G). We note that the 3mTagBFP2 also occasionally
made cytosolic foci, possibly due to self-oligomerization.
To monitor microtubules, we introduced the three fluorophores at
the N-terminus of α-tubulin (atb2) and used its 5′ and 3′ regulatory
sequences to drive expression of the construct as a second copy
without perturbing the native α-tubulin locus (Fig. 4H; Movie 1).
We monitored the actin cytoskeleton using the LifeAct probe (Riedl
et al., 2008) fused to a red or a green fluorophore (Fig. 4I; Movie 1).
We also expressed LifeAct fused to mTagBFP2, but these cells
Fig. 3. Expanding the SIV toolbox. (A) Schematics of cloned vectors with indicated genomic-targeting loci (orange), antibiotic resistances (mustard) and multiple
cloning sites (MCSx). Note that not all sites are unique in all vectors. Complete vector sequences are provided in Figshare Source Data D1 to plan cloning.
(B) Schematics of cloned vectors with indicated genomic targeting loci (orange), promoters (turquoise) and MCS. The STOP codon is placed between restriction
enzyme sites, which allows to use the vectors for both N- and C-terminal sfGFP tagging. Note that not all sites are unique in all vectors, and that KpnI and SacI
(highlighted) can be used to shuttle the entire constructs between vectors of this and the series presented in (A). (C)Quantification (top panel) ofwestern blots against
sfGFP (middle panel) and tubulin (bottompanel, loading control) performedon lysates obtained fromcells where sfGFPwasexpressed from the indicatedpromoters.
(D) Fluorescence profiles obtained by flow cytometry from cells with indicated genotypes. Note that there are no significant differences in expression of sfGFP from
the act1 promoter integrated at anyof the four different genomic loci as suggested by theWelch testP-values that are also reported. (E) Quantification of fluorescence
emitted by the sfGFP that was expressed from the indicated constitutive, induced and repressed promoters. Bars report mean values from multiple cells and
error bars report standard deviation. The turquoise lines on the top of the graph indicated samples which differ with P-values lower than 0.02 according to the
Kruskal–Wallis test. (F)Micrographs of Ltc1–sfGFPexpressed from indicated promoters of different strengths and imagedwith indicated exposure times. Please note
that fluorescent foci (arrows) are barely notable above cell autofluorescence when Ltc1–sfGFP is expressed from the native ltc1 locus but become clearly
evident when using the pom1, rga3, or pak1 promoters. Also note that using the strong act1 promoter results in ectopic localization throughout the ER.
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exhibited growth defects (Fig. S2). As an alternative probe to
visualize the actin cytoskeleton, we fused the calponin homology
domain (CHD) of Rng2 protein (Wang et al., 2004) with either red
or blue fluorescent protein (Fig. 4J; Movie 1). We note that cells
expressing 3mTagBFP2–CHD exhibited abnormally abundant,
likely stabilized actin cables. We fused the N-terminal signal
Fig. 4. Panel of cell biology probes generated using SIV toolbox.Micrographs of cells expressing green, red and blue fluorescent probes to visualize (A) cells,
(B) P- and M-gametes, (C) plasma membrane, (D,E) nucleus and/or nuclear import, (F) nuclear export, (G) nuclear integrity, (H) microtubules, (I,J) actin
cytoskeleton, (K) endoplasmic reticulum, (L) active Cdc42, (M) active Ras1 and (N) DNA replication foci (arrowheads). Please see the figure and the text for detail
of the constructs.
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sequence from BiP to target either sfGFP or mCherry to the ER and
ensured its retention in the ER with the C-terminal ADEL sequence
(Fig. 4K) (Zhang et al., 2010). We also attempted to generate a blue
ER marker but did not observe any fluorescence. We expressed the
CRIB–3GFP probe to monitor the GTP-bound form of the small
GTPase Cdc42 using the ppak1 promoter as previously reported
[note that this CRIB probe is 27 aa shorter than that described in
Tatebe et al., (2008); Fig. 4L, left panel, Movie 1]. CRIB fused to
triple mCherry or mTagBFP2 was reliably observed only when the
construct was expressed using the stronger pact1 promoter (Fig. 4L,
middle and right panels; Movie 1). We used the RasAct probe to
monitor the GTP-bound form of the small GTPase Ras1 as
previously reported (Merlini et al., 2018; Fig. 4M, Movie 1).
Finally, to monitor cell cycle progression, green and red fluorescent
proteins were fused with Pcn1, the PCNA component of the
replisome, and the construct was expressed in addition to the native
gene (Meister et al., 2007; Fig. 4N, Movie 1). Pcn1 produced a
uniform nuclear signal except in S-phase cells undergoing DNA
replication when distinct fluorescent foci representing replication
factories are observed (Fig. 4N, arrowheads).
Taken together, our work provides a panel of frequently used
live-cell probes that are stably expressed from a single genomic copy
introduced using the vectors we developed.
DISCUSSION
We present here a large series of modular vectors for stable, single-
copy integration in the fission yeast genome. This vector series
expands the genetic toolbox of the popular fission yeast model
Schizosaccharomyces pombe. For the reasons highlighted below,
these vectors currently are the best tools to introduce foreign genetic
material in the genome in a controlled manner. We thus encourage
their wide use and further development. The vectors and strains
developed herein are available from the Japanese National
BioResource Project (NBRP; http://yeast.nig.ac.jp/yeast/) and the
non-profit plasmid repository Addgene (https://www.addgene.org/).
IDs for these repositories are provided in Table S1.
Stable and single-copy genomic integration
The controlled expression of desired genetic information is a
powerful way to probe gene functionality. The popular model
Schizosaccharomyces pombe can easily be transformed with
plasmids, which have been the vector of choice for introduction
of exogenous DNA. However, the fact that fission yeast centromeres
are large, complex genomic elements has hindered development of
centromeric plasmids such as those developed in budding yeast
(Clarke and Carbon, 1980). Furthermore, fission yeast cells do not
naturally carry plasmids such as the budding yeast 2 µ plasmid,
which carries a partitioning system (Chan et al., 2013; Strope et al.,
2015). Instead, fission yeast research has relied on either
autonomously replicating episomal plasmids or on vectors
integrating into the genome. Episomal vectors, such as the widely
used pREP series (Maundrell, 1993), segregate randomly between
daughter cells at division, which results in a copy number variation
within the clonal population. Furthermore, the plasmid selection has
to be continuously applied or the plasmid is rapidly lost, in
particular as cells go through sexual reproduction. Most integrative
plasmids (Keeney and Boeke, 1994; Maundrell, 1993) carry a single
homology region that targets them into the desired locus of the
genome. While efficient and precise, vector integration produces
genomic repeats, which can recombine and remove the integrated
segment. With a rate of plasmid sequence loss from integrant strains
at ∼5×10−4 over 3 days (Fig. 1D), integrated DNA that decreases
cell fitness would be rapidly eliminated from the population. This is
likely to be particularly prominent in genetic crosses, when genomic
repeats misalign between parental chromosomes during meiotic
recombination (Smith, 1976). In summary, most traditionally used
vectors suffer from instability and copy-number variation.
To overcome this problem, we developed pUra4AfeI, pAde6PmeI,
pLys3BstZ17I and pHis5StuI plasmids, which rely on two homology
arms to integrate into the genome (Figs 1A and 2A). These vectors
recombine specifically with their target genomic locus (Fig. S1B).
Importantly, we have shown that integration of these vectors occurs
without producing genomic repeats, and leads to a stable genomic
copy that is not lost when cells are grown without selection
(Figs 1C,D and 2B). The vectors also predominantly integrate as a
single copy (Fig. 2F), which ensures that copy-number is not a
confounding factor when comparing the biological activity of
different constructs. Thus, these vectors allow reliable stable, single-
copy genomic integration.
Comparison with other vector series and approaches
Integrative plasmids that rely on two homology arms have
previously been developed by the Hagan/Simanis and Sato groups
(Fennessy et al., 2014; Kakui et al., 2015). The first of these studies
presented a highly modular series of integrative vectors that uses the
Golden Gate cloning scheme to join upwards of eight fragments
together in a single ligation reaction and generate vectors integrating
at lys1, arg1 and two intergenic regions of chromosome I and II. The
second reported three vector series integrating at leu1, lys1 and an
hphMX cassette previously integrated at an intergenic region of
chromosome III. Although the design of these plasmids with two
homology arms is predicted to yield stable integrants, whether the
different genomic loci chosen as integration sites exhibit similar
properties to the ones we describe for ura4, ade6, lys3 and his5
remains to be seen, as neither stability of integration nor number of
integration events have been reported. It may be unwise to assume
that all sites of integration behave similarly. Indeed, we found here
that targeting the leu1 locus with a plasmid carrying two homology
arms (pLeu1StuI) did not systematically lead to stable genomic
integration. One possible explanation is that the leu1 sequence
contains a replication origin, which may allow the cells to
transiently maintain the plasmid as an episomal element if it is re-
circularized by non-homologous end joining. Indeed, a potential
replication origin resides at the leu1 locus (originID: II-1983; Siow
et al., 2012). The design of these previously described plasmids
generates another major difference with the set of integrative
plasmids described here: when vectors integrating at lys1, arg1 or
leu1 are chosen, their integration leads to disruption of the target
genomic site, and thus the creation of auxotrophic strains. By
contrast, integration of the plasmids presented here restores (or
preserves) the target locus and thus forms prototrophic
transformants, which may be beneficial for the study of many
physiological pathways (Alam et al., 2016). We note that it may be
possible to combine the modularity of the Golden Gate cloning
scheme described in Kakui et al., (2015) with the now established
stability of integration and production of prototrophic transformants
at ura4, ade6, lys3 and his5 by constructing a Golden Gate target
modules donor vector using the four target integration sequences
characterized here.
We designed and tested SIV plasmids properties in targeting
specific genomic loci (Figs 1 and 2). These vectors are not ideally
suited for modification of genes at their native locus. For this, a
method of choice is the amplification by PCR of integration
cassettes for gene disruption or tagging with primers that introduce
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80 bp homology arms to the genomic locus of interest (Bähler
et al., 1998; Wach et al., 1994). A large panel of pFA6a-based
vectors, which are widely used in the field and have been
optimized for both gene deletions and gene tagging with a wide
range of tags (Bähler et al., 1998; Chen et al., 2017; Gadaleta et al.,
2013; Hentges et al., 2005; Sato et al., 2005; Van Driessche et al.,
2005), can be used as template. For genomic loci exhibiting less
efficient homologous recombination, extending the length of the
homology arms is beneficial. For this, we typically construct an
integrative plasmid that can be linearized between two homology
regions to either side of the target integration site. The integration
cassette, conceptually similar to those used to target integration
of vectors described here, can easily be constructed in a single
step, for instance using InFusion or overlapping PCR, and
integrated in the pFA6a vector series. In conclusion, SIV
plasmids add to the existing panel of tools available to fission
yeast researchers.
Plasmid modularity and versatility
Because every experimental design is different and there is no single
vector that can fit all needs, the vector series presented here has been
developed with modularity in mind. Simple subcloning can easily
re-target a construct to a different genomic locus, introduce a
different selection marker, exchange the fluorescent tag or alter the
level of expression. We already generated a set of highly used cell
biology markers that can be combined through genetic crosses and
are predominantly away from the most frequently targeted ura4
locus. These can also be targeted to different loci or in other colour,
at will. We encourage the further expansion of the SIV series
through introduction for instance of additional tags or inducible
promoters (Kjaerulff and Nielsen, 2015; Ohira et al., 2017; Zilio
et al., 2012).
The design choice will be dictated by the experiment (see section
on ‘Recommendations for use of the vectors’ below for
recommendation on experimental design and plasmid use). For
instance, while selecting for prototrophs is more cost effective, this
requires transformation into an auxotrophic strain. For this, both
strains carrying point mutations, which are present in most strain
collections, and the new deletion alleles we constructed (ade6-D19,
lys3-D20 and his5-D21; Figs 1F,G and 2C,D), as well as the
previously described ura4-D18 allele (Grimm et al., 1988), are
suitable. However, we find that prototrophic restoration of the
selective marker without integration of the accompanying vector
sequences occurs in up to 8% of the total transformants when using
point mutants (Figs 1F,G and 2C,D). Thus, strains with deletion
alleles should be used when it is important to avoid false-positive
transformants. For example, high rates of false-positive
transformants may make it complicated to quantify how
introducing genes of interest affects the capacity of cells to form
colonies (Li and McLeod, 1996). High rates of false-positive
transformants may also increase the aworkload when screening
transformants obtained using a plasmid library. Using deletion
alleles in the parental strain precludes homologous recombination of
the selective marker alone, but we note that unintended transformant
genotypes may still rarely arise when integration is achieved by non-
homologous repair (Chang et al., 2017; Fennessy et al., 2014). The
vector variants containing an antibiotic selection marker (Fig. 3A)
should also exhibit low false-positive rates when selecting for the
antibiotic resistance but not when selecting for prototrophic
transformants. The plethora of dominant antibiotic resistance
markers is particularly useful since vectors can be directly
integrated into most genetic backgrounds without the need for a
pre-existing auxotrophy. The limit would only be reached in
prototrophs already containing the five different antibiotic
resistances used here.
The series of the promoters we provide induces expression levels
that span more than three orders of magnitude and thus should
accommodate a wide range of applications. We note that, for the same
promoter, we did not observe changes in expression levels between
different genomic loci (Fig. 3C,D). However, we refrain from using
different constructs to compare between conditions as genomic
position effects may become evident only in certain backgrounds
(Allshire and Ekwall, 2015). While we present the full vector series
for the first time here, some plasmids have been used in published
studies (Billault-Chaumartin and Martin, 2019; Gerganova et al.,
2019; Lamas et al., 2019 preprint; Marek et al., 2019 preprint;
Vještica et al., 2018), which illustrates their application in fission
yeast research.
Recommendations for use of the vectors
For best use of the tools described here, we make a few
recommendations as follows:
1. Clone your construct in your plasmid of choice according to
experimental design, bearing in mind that the restriction
enzyme used for linearization (AfeI, PmeI, BstZ17I or StuI in
pUra4AfeI, pAde6PmeI, pLys3BstZ17I and pHis5StuI, respectively)
should remain unique after cloning.
• In some cases, combinations of other restriction enzymes
can be used for linearization as long as they produce a single
linear fragment with two large homology arms (e.g. RsrII
and BlpI can be used together on pAde6PmeI);
• Bear in mind that the multiple cloning sites between
plasmids of the same sets are identical but not all restriction
enzymes are unique in all cases. While plasmids carrying
the antibiotic-resistance markers are designed to receive
constructs from other plasmids by SacI-KpnI digestion,
antibiotic markers can also be shuttled into the promoter
series by using a unique site in either the ColE1 or AmpR
genes and SacI or BglII;
• Blunt restriction enzyme sites (e.g. PmlI, SmaI, SwaI) have
been introduced in some of the plasmids to increase their
modularity. Similarly, restriction sites that use compatible
cohesive ends (e.g. XhoI-SalI pair) increase the ability to
shift constructs between plasmids;
• In our experience, a single ligation reaction can readily
combine three elements into a single plasmid (e.g. pact1 cut
with KpnI and EcoRI from pAV0714, mTagBFP2 cut with
EcoRI andAscI from pAV0471 and the vector sequences from
pAV0783 cut with KpnI and AscI);
• Other protein tags can be cloned in place of the sfGFP
sequence, preserving the STOP codon in the MCS after the
tag, to allow for both N- and C-terminal tagging;
• In addition to the main 22 plasmids discussed in the text,
we also provide 22 plasmids that were used in building the
strains presented in Fig. 4. These include additional
promoters (e.g. the constitutive promoter patb2 and pbip1,
and the mating type-specific promoters pmam1* and pmap3),
fluorophores (e.g. 3GFP, 3mCherry, 3mTagBFP2) and a
terminator (S. cerevisiae ADH1) that may be better suited for
some uses.
2. Linearize 700 µg of the plasmid and transform in the strain,
using either prototrophy or antibiotic selection;
3. Verify correct integration by diagnostic PCRs on both sides of
the integration sites with primers as described in Fig. S1.
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MATERIALS AND METHODS
Plasmids
All plasmids were generated using standard restriction enzyme cloning and
InFusion system (TaKaRa Bio, Kusatsu, Japan). The list of all plasmids used
in the study is available in Table S1. Annotated GenBank format sequences
for all constructs used in the study are available from Figshare (https://doi.
org/10.6084/m9.figshare.10689188.v1, source data D1). Plasmids that are
of general use are available from Addgene (Watertown, USA; https://www.
addgene.org) and the Japanese National BioResource Project (NBRP,
Osaka, Japan; http://yeast.nig.ac.jp). All plasmids used to test the system,
which are derivatives of the ones available from these resource centers, are
available from the Martin laboratory upon reasonable request.
The plasmid backbones were amplified from pJK210 which itself was
derived from pBluescript SK (+) and encode for ColE1 and F1 replication
origins, ampicillin selection cassette, a multiple cloning site and T3, T7 and
M13 primer sequences. Dominant selection markers kanMX6, natMX6,
hphMX6, bleMX6 for yeast selection were amplified from the pFA6a vector
series (Bähler et al., 1998; Hentges et al., 2005; Wach et al., 1994). The
bsdMX6 selection marker was amplified from the fission yeast strain
VS6381, a kind gift from Viesturs Simanis (EPFL, Switzerland) and
Masamitsu Sato (Waseda University, Japan). We noticed sequence variation
in comparison to original sequences, but report that all markers were fully
functional. All fission yeast sequences were amplified from the genomes of
wild-type strains 968 (ySM1396), 972 (ySM995) or 975 (ySM1371).
Forpromoter sequences,we used the sequences immediatelyupstreamof the
START codon. Promoter ptdh1 contains 1000 bp, while ptdh1* contains 896 bp
(used only in pAV0471, pAV0765, pAV0532 and pAV0569–pAV0572). pact1
includes 822 bp, prga3 includes 1203 bp, ppom1 includes 688 bp, pmap3 includes
2063 bp, patb2 includes 647 bp, pbip1 includes 988 bp, ppcn1 includes 1954 bp,
ppak1 includes 630 bp, purg1 includes 675 bp and pnmt1 includes 1177 bp. The
pnmt41 and pnmt81 promoters were obtained by subsequently mutating the pnmt1
using nested PCR (with mutations as reported in Basi et al., 1993). pmam1*
includes 1751 bp and was point mutated to remove the AfeI site.
For terminator sequences, we used the sequences immediately after the
STOP codon of Saccharomyces cerevisiae genes ADH1 (229 bp) and CYC1
(250 bp). We also used the 988 bp downstream of the fission yeast nmt1
gene STOP codon. In case of sequences designated as the tdh1 terminator,
we used a fragment containing the sequence between STOP+332 bp and
STOP+1032 bp. We note that this fragment does not include the 3′UTR
sequence of the tdh1 gene but led to a notable increase in protein levels as
compared to constructs lacking any terminator sequence.
Fluorescent protein sequences were obtained from laboratory stocks with
the exception of mTagBFP2 which was amplified from mTagBFP2-pBAD
(Addgene #54572). The 3mTagBFP2 was a kind gift from Serge Pelet
(University of Lausanne, Switzerland).
All the probes are derived from previous publications. The RitC
amphipathic helix encodes the 62 C-terminal amino acids from the
mammalian Rit protein (Onken et al., 2006). The nuclear localization
signal uses the viral SV40 motif (PKKKRKV, Kalderon et al., 1984).
Nuclear export signals were derived from fission yeast genes Mia1/Alp7
(EDLVIAMDQLNLEQ, Ling et al., 2009) and Wis1 (QPLSCSLRQLSISP,
Nguyen et al., 2002). The CRIB probe encodes amino acids 2–181 from
S. cerevisiae protein Gic2, in contrast to CRIB construct used by Tatebe
et al. (2008) which used amino acids 1–208. The RasAct probe encodes
Byr1 amino acids 65–180 in three tandem repeats (Merlini et al., 2018). The
LifeAct probe encodes a MGVADLIKKFESISKE peptide (Riedl et al.,
2008). The CHD probe contains amino acids 1–189 from the Rng2 protein
(Wang et al., 2004). The N-terminal signal sequence comprising amino
acids 1–25 from the BiP (Bip1) protein targets the fluorophore to the ER
while the C-terminal ADEL motif ensures its retention in the ER (Zhang
et al., 2010). Microtubules are visualized by use of full-length Atb2
(Cassimeris and Tran, 2010) and replication sites by use of Pcn1 (Meister
et al., 2007), both tagged at the N-terminus and expressed as a second copy.
Growth conditions
Yeast cells were grown in standard fission yeast medium at either 25°C or
30°C (Hagan, 2016) and using 200 rpm rotators for liquid media. For genetic
manipulations we used YES medium. For selection we supplemented YES
with 100 µg/ml G418/kanamycin (cat. no. G4185, Formedium, Norfolk, UK),
100 µg/ml nourseothricin (HKI, Jena, Germany), 50 µg/ml hygromycinB
(cat. no.10687010, Invitrogen), 100 µg/ml zeocin (cat. no. R25001, Thermo
Fisher Scientific), and 15 µg/ml blasticidin-S (cat. no. R21001, Thermo
Fisher Scientific). 5-FOA (cat. no. 003234, Fluorochem, Derbyshire, UK)
was used at 1 mg/ml in Edinburgh minimal medium (EMM) supplemented
with 50.25 µg/ml uracil (U0750-100G, Sigma-Aldrich, St Louis, MO). For
western blotting, flow cytometry and imaging, we used EMM-ALU
medium, which is EMM medium supplemented with 255 μg/ml adenine
hemisulfate (A9126-100G, Sigma-Aldrich), 255 μg/ml leucine (L8000-
100G, Sigma-Aldrich) and 255 μg/ml uracil (U0750-100G, Sigma-
Aldrich). Briefly, cells were precultured overnight in liquid EMM-ALU
and then again sub-cultured overnight to reach the exponential phase.
Repression of the nmt promoters was achieved by supplementing thiamine at
final concentration of 5 µg/ml. Activation of the nmt promoters was
achieved by washing out thiamine and growing cells for minimum of 24 h.
The urg1 promoter was induced by addition of uracil at final concentration
250 µg/ml for at least 48 h. Conditions used to mate cells are detailed in
Vjestica et al. (2016). Briefly, cells were precultured overnight in MSL+N
media and then sub-cultured overnight to reach the exponential phase. Cells
of opposite mating types were then mixed in equal amounts, washed three
times and resuspended inMSL-N to give a final OD600nm=1.5 and incubated
at 30°C with 200 rpm agitation for 4–6 h prior to mounting for imaging.
Yeast strains
The list of all strains used in the study is available in Table S2. Strains of
general use are available from the Japanese National BioResource Project
(NBRP, Osaka, Japan; http://yeast.nig.ac.jp).
All fission yeast strains were obtained by standard lithium acetate
transformation protocol (Hagan, 2016). We used ∼700 ng of the linearized
plasmid per transformation. Unless otherwise indicated, plasmids were
linearized with a single restriction enzyme present in between the two
homology regions (e.g. AfeI for pUra4AfeI). In some instances, subcloned
constructs contained an additional cutting site for the enzyme normally used
to linearize the vector. As indicated in the yeast strain table (Table S2), we
overcame this problem by using two enzymes that flank the regular linearization
sites (e.g. RsrII and BlpI for pAV0782) which leads to slightly shorter
homology arms. This did not affect the ability to obtain correct transformants.
The ura4-294, ade6-M210, lys3-37 are commonly used S. pombe point
mutant strains that are available in many lab stocks. The his5Δ1 strain was
obtained from Dr Mohan Balasubramanian (Warwick Medical School,
University ofWarwick, UK) (Tang et al., 2011). ade6-M210 carries a C1466T
substitution, whereas the exact mutations of other alleles are not known. The
auxotrophic ura4-D18mutation (Grimm et al., 1988), which lacks the 1.8 kb
HindIII fragment flanking the ura4 ORF, was obtained by crossing out from
the Martin group yeast library (YSM1131). To generate auxotrophic ade6-
D19, lys3-D20 and his5-D21 deletions, we first inserted the ura4+ selection
cassette into the pAde6PmeI, pLys3BstZ17I and pHis5StuI vector to obtain
plasmids pAV0596, pAV0597 and pAV0598. The resulting plasmids were
linearized to target their integration at the ade6, lys3 and his5 genomic loci,
respectively. Each linearized plasmid was separately transformed into the
yeast strain carrying the ura4-D18 mutation. Selection for uracil prototrophy
yielded strains where a functional ura4+ cassette was now linked with either
ade6, lys3 or his5 locus, while the native ura4 locus carried the ura4-D18
mutation. These strains were then transformed with DNA fragments spanning
both sides of the ura4+ integration site and carrying the ade6-D19, lys3-D20
or his5-D21 deletions (see Supplemental Sequences). Recombinants that
remove the ura4+ cassette and replace the locus with the deletion allele were
selected on 5-FOA. The ade6-D19 allele is lacking the fragment from
STOP−776 bp to STOP+159 bp, the lys3-D20 allele lacks sequences
between STOP−895 bp and STOP+367 bp, and the his5-D21 allele lacks
the fragment from STOP−524 bp to STOP+378 bp. The correct
transformants were confirmed by diagnostic PCRs (the PCR-PΔ indicated
in the Fig. S1) and then backcrossed six times with the wild-type fission yeast
strain 975 (YSM1371) to obtain the final strains. The h90 strains were
obtained through crosses with wild-type fission yeast strain 968 (YSM1396).
All other strains were obtained by transforming linearized plasmids into
either auxotrophic strains and selecting for prototrophs, or into prototrophs
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and selecting for antibiotic resistance. Multiple transformants were
genotyped to verify correct plasmid integration. Since expression levels
between several transformants did not vary, we assumed that they all carried
a single integrated copy.
gDNA extraction
Genomic (g)DNAwas extracted using a protocol described by Lõoke et al.
(2011) with minor modifications. Briefly, ∼5×107 of freshly streaked cells
was resuspended in 100 μl of the isolation buffer (250 mM lithium acetate
and 1% SDS) in a microfuge tube. Samples were incubated for 10 min at
70°C and briefly vortexed.We added 300 μl of 100% ethanol to each sample
and briefly vortexed. Next, we spun down the samples at 15,000 g for
3 min. The pellet was washed with 70% ethanol twice. The pellet was
briefly dried to remove traces of ethanol. We then dissolved the pellet in
100 μl of 5 mM Tris-HCl and spun down the cell debris for 1 min at
3000 g. The supernatant was transferred to a fresh tube and the concentration
was adjusted to 100 µg/ml. The samples were used for both standard and
quantitative PCR amplifications.
Genotyping
An overview of the diagnostic PCR reactions used to confirm genomic
integration of the vector at the desired locus is presented in Fig. S1.
Sequences of the primers used are available in Table S3. Briefly, we tested
recombination for each homology arm of the vectors by PCRs with one
vector-specific and one genome-specific oligonucleotide (Fig. S1, right
panel). Simultaneously we tested for the presence of the parental locus using
two genome-specific oligonucleotides. We used different primers to test the
prototrophic and auxotrophic parental loci. Only transformants where all
three PCRs indicated correct integration were used further.
Standard PCRs were performed with 5 µM primers, 5 ng/µl of the gDNA
and a polymerase made in-house using the following cycler program:
98C
150 s
! 30 98
C
20 s
! 54
C
30 s
! 72
C
90 s
 
! 72
C
600 s
:
The ade6 PCR-U (Fig. S1) was performed with commercial Kapa-Taq
(Kapa Biosystems, Wilmington, NC) and the PCR program:
96C
150 s
! 35 96
C
30 s
! 51
C
30 s
! 72
C
180 s
 
! 72
C
600 s
:
Quantitative PCR
We used qPCR to monitor the number of plasmid integration events into the
genome. The raw EDS format data (Source Data D2) and processed results
(Source Data D3) are available from Figshare (https://doi.org/10.6084/m9.
figshare.10689188.v1). Experiments were performed on the QuantStudio™5
(Applied Biosystems) using SYBR Select Master Mix (Applied Biosystems;
cat. no. 4472908) and primers at a final concentration of 0.2 µM. The final
reaction volume was 10 µl. Each biological sample was evaluated in a
technical triplicate. Technical outliers were rare and were not removed. Each
experiment included a negative control (water), which did not show any
considerable signal amplification. An identical detection threshold of
fluorescence intensity was set for all targets and all qPCR samples in the
study, and used to determine the cycle threshold (Ct) value. We monitored
amplification of a ura4 142 bp fragment using primers osm6182 (5′-GGC-
TGGGACAGCAATATCGT-3′) and osm6183 (5′-GCCTTCCAACCAGC-
TTCTCT-3′) and act1 149 bp fragment using primers osm6178 (5′-
GTGTTACCCACACTGTTCCCA-3′) and osm6179 (5′-TTCACGTTCGG-
CGGTAGTAG-3′).We first amplified the 10-fold dilution series of wild-type
genomic DNA (extraction protocol as detailed above) at final
concentrations in the range 0.01–100 ng/µl, which established primer
efficiencies of 1.99 (R2=0.998) and 2.04 (R2=0.999) and intercepts of
18.53 and 19.06 for ura4 and act1 primer pairs, respectively. In
subsequent experiments, we used genomic DNA at a final concentration
of 10 ng/µl and the formula:
½ura4
½act1 ¼
1:9918:53Ctura4
2:0419:06Ctact1
to compare relative levels of ura4 and act1 loci. We proceeded to show that
we can reproducibly detect a relative increase in ura4 locus copy number
by using strains that carry one (ySM1371: wt, ura4+), two (AV0138:
pak2Δ:ura4+ ura4+) and three (AV0226: myo52Δ:ura4+ pak2Δ:ura4+
ura4+) copies of the ura4 locus but only one act1 locus. All subsequent
experiments included each of these samples as positive controls.
To quantify the number of integrated copies of the vectors pJK210 and
pUra4AfeI we transformed the linearized vectors into ura4-294 and ura4-
D18 auxotrophic strains, respectively, and extracted the genomic DNA
from 12 prototrophic transformants. qPCR analysis of relative ura4
and act1 loci abundance was used to determine the number of
integration events. For vectors pAde6PmeI, pLys3BstZ17I and pHis5StuI,
we first introduced the ura4 cassette to produce plasmids pAV0596,
pAV0597 and pAV0597. Linearized vectors were transformed into ade6-
D19 ura4-D18, lys3-D20 ura4-D18 or his5-D21 ura4-D18 double
mutants, respectively, and selected for uracil prototrophy. A total of 12
transformants from each transformation were then used to extract gDNA,
establish relative levels of act1 and ura4 loci, and determine the number of
integration events.
Quantification of false-positive integrants and transformation
efficiencies
To measure the proportion of false-positive integrations, we introduced
sfGFP under the strong tdh1 promoter into pUra4AfeI, pAde6PmeI,
pLys3BstZ17I and pHis5StuI plasmids, which resulted in plasmids
pAV0569, pAV0570, pAV0571 and pAV0572. After linearization, the
plasmids were transformed into adequate auxotrophic strains and plated on
media selecting for prototrophy. The transformation efficiency was
calculated as the proportion of cells that formed colonies from the total
number of cells that was transformed. Once colonies formed, we imaged the
selective plates using Fusion FX (Vilber, Collégien, France). While white
light was used to observe all clones, we detect the green fluorescent protein
using the 480 nm LED illumination and the F535Y filter (535/50). This
allowed us to distinguish between fluorescent and non-fluorescent
clones. The percentage of non-fluorescent colonies was used as a
measure of false-positive transformants. We report the mean±s.d. of three
independent experiments. We also report the P-values from the paired
Student’s t-test.
Quantification of stability of loci generated by plasmid
integration
To quantify the stability of loci generated by integration of pJK210 and
pUra4AfeI plasmids, we exploited the 5-FOA counter-selection against ura4+.
First, we cloned the natMX6 cassette into the two vectors to obtain plasmids
pAV0584 and pAV0623. The resulting plasmids were linearized, transformed
into cells carrying the ura4-294 point mutation and, for each transformation,
six nourseothricin-resistant uracil prototrophs were selected. To reveal any
instability in the introduced loci, we grew the 12 transformants, and an
additional four clones of the wild-type prototrophic strain, as a negative
control, on non-selective (uracil supplemented, no nourseothricin) medium
for 3 days. The strains were first passaged twice on non-selective solid
medium over 2 days. We then precultured each clone in non-selective, liquid
medium overnight to exponential phase and plated 1.4×107 cells onto 5-FOA
medium containing uracil, which selects for ura4− cells. 5-FOA-resistant
clones were replica plated onto medium containing nourseothricin to check
whether the entire locus was lost.We report the average proportion of 5-FOA-
resistant clones out of 1.4×107 cells that we plated, and the percentage of
those that retained the nourseothricin-resistance marker. Significance was
determined using the Kruskal–Wallis test.
Since drugs to counter-select against ade6+, lys3+ and his5+ were not
available, we introduced both the ura4+ and an antibiotic cassette into
pAde6PmeI, pLys3BstZ17I and pHis5StuI plasmids, which resulted in plasmids
pAV0616, pAV0617 and pAV0618. This allowed us to use the same
strategy as above to quantify the stability of loci generated by our vector
series, the only difference being that we performed it using four and not six
initial transformants. Significance was determined using the Kruskal–
Wallis test.
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Microscopy and image quantification
All images shown in Fig. 4 were obtained by wide-field microscopy
performed on a DeltaVision platform (Applied Precision) composed of a
customized inverted microscope (IX-71; Olympus), a UPlan Apochromat
100×/1.4 NA or 60×/1.4 NA oil objective, a camera (CoolSNAP HQ2;
Photometrics), and a color combined unit illuminator (Insight SSI 7; Social
Science Insights). Images were acquired using softWoRx v4.1.2 software
(Applied Precision). The mTagBFP2 was imaged using the DAPI/FITC/
TRITC/CY5™ filterset which allows bandpass excitation (390/18) and
emission (435/48). We used the GFP-mCherry™ filterset to detect the green
(excitation 475/28, emission 525/50) and red (excitation 575/25; emission
632/60) fluorescent proteins. We imaged a different number of Z-sections to
best capture the structure of interest. We present either a single Z-plane or a
projection image. All image processing was performed using standard
ImageJ/Fiji (NIH, Bethesda, USA) built-in modules, except for images where
deconvolution was performed using the softWoRx v4.1.2 built-in module.
To quantify relative promoter strengths, we imaged cells expressing
sfGFP from the indicated promoters, using a spinning disk confocal setup
comprising a DMI4000B inverted microscope equipped with an 100× HCX
PL APO 6100 (NA 1.46) oil objective and Perkin-Elmer Confocal system
(including a Yokagawa CSU22 real-time confocal scanning head and solid-
state laser lines). Z-series of confocal sections were acquired at 0.4 μm
intervals using the Volocity software.
For quantifications, we prepared an average projection image of three
medial Z-sections. Next, we outlined the cell boundaries and measured the
mean fluorescence intensity of at least 25 untagged wild-type cells and 25
cells expressing cytosolic sfGFP from the indicated promoters. Next, we
subtracted the mean fluorescence of wild-type cells from each cell carrying
the sfGFP gene that was imaged in identical conditions. We then calculated
the mean intensity and standard deviation for cells of the same genotype.
Since sfGFP expression levels induced by different promoters varied by
more than three orders of magnitude, the samples imaged under the same
imaging conditions were standardized to the signal from ura4+:pact1:sfGFP
cells, which was set to 100 arbitrary units. The data presented is the mean
intensity, and standard deviation is denoted.
For images in Fig. 4, we concentrated exponentially growing cells by
centrifugation at 1000 g and spotted them directly between slide and coverslip
for immediate imaging. For images in Fig. 3 and time-lapse imaging, we
placed cells in chambers with solid medium made with 2% agarose, as
previously described (Vjestica et al., 2016).
Western blotting and protein level quantification
We grew 70 ml of each strain in EMM, supplemented with 5 µg/ml of
thiamine or 50.25 µg/ml of uracil as indicated, to exponential phase and
collected cells by centrifugation for 5 min at 1000 g. Samples were frozen in
liquid nitrogen and stored at −80°C until ready for processing. Subsequent
steps were performed at 4°C. Samples were thawed and transferred into 2 ml
microcentrifuge tubes, washed twice with ice-cold PBS buffer (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.5, and
protease inhibitor mix) and re-suspended in 500 µl of the PBS buffer. ∼1 ml
of acid-washed glass beads were added. Cells were lysed using the FastPrep-
24 bead-beater (MP Biomedicals, Santa Ana, CA) set to 4.5 m/s with
10 cycles of 20 s beating and 40 s cooling on ice. We then pierced the
bottom of the tube with a heated needle, placed that tube into a 1.5 ml
microfuge tube and centrifuged it at 150 g for 60 s. In this manner, we
discarded the beads and transferred the samples to a new tube. Cell debris
was pelleted by centrifugation for 15 min at 13,000 g. We collected the
supernatant and determined the protein concentration using the Bradford
assay. All samples were adjusted to the same protein concentration and re-
suspended in Laemmli buffer, heated to 90°C for 5 min and then subjected
to SDS-PAGE (XP10205BOX, Thermo Fisher Scientific). The gel was then
blotted onto nitrocellulose membrane using the Towbin transfer buffer
(25 mM Tris base, 192 mM glycin, 20% methanol, pH 8.3). After blocking
in 5% milk, the membrane was first probed with an anti-GFP antibody (cat.
no. 11814460001, Roche, Basel, Switzerland; 1:3000 dilution) followed by
a secondary anti-mouse-IR800 (R-05061, Advansta, Menlo Park, CA), and
visualized on the Fusion FX (Vilber, Collégien, France). Subsequently, the
same membrane was probed with the anti-TAT-1 antibody (a kind gift from
Keith Gull, University of Oxford, UK; used at 1:3000 dilution) targeting
tubulin as a loading control. We used ImageJ/Fiji to quantify the signal
detected for GFP and normalized it to the tubulin signal. We used the
unlabelled area of the membrane as the background intensities. The
experiment was qualitatively reproduced in two independent replicates and
results quantified from the second replicate.
Flow cytometry
Flow cytometry was performed on a BD Biosciences Fortessa analyser
using CellQuest software. To stain for dead cells in the population, cells
were diluted in EMM-ALU medium to final OD600 0.4 and 100 μl of cell
suspension was mixed with 900 µl EMM-ALU medium containing 1 μg/ml
propidium iodide (PI). After 30 s of incubation cells were analysed by flow
cytometry without gating during acquisition with 104 cells recorded for each
sample. Data were analysed using the FlowJo software package using the
following gating strategy: (1) the main cellular population was distinguished
using forward and side scatter to exclude cell aggregates, (2) doublets were
excluded from analysis by plotting FSC-A versus FSC-H and gating along
the diagonal, (3) dead cells were excluded from analysis by gating out
PI-positive events, and (4) GFP-positive events were detected in the green
channel. More than 70% of all events passed the indicated criteria.
Statistical analysis
Statistical tests used were the Kruskal–Wallis or Student’s t-test, as
described above. Sample sizes were not pre-determined. No sample was
excluded. No randomization or blinding was used.
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Figure S1. Diagnostic PCRs to test SIV genomic integration
(A) Overview of the genotyping strategy to test for correct integration of the plasmids targeting the indicated genomic loci. The top schematic shows parental and transformant loci where
arrows denote the primers used for genotyping and colored areas the segment amplified by PCRs. The specific primers carrying the “osm” identifier, and the sizes of the PCR fragments
they produce are denoted for each genomic locus. For primer sequences please see Supplemental Table S3. The left and middle panel show the diagnostic PCR for the presence of the
parental locus. The PCR-P is used when transformants are obtained from wildtype and point-mutant target alleles, and PCR-P∆ when the parental strain is a deletion of the target locus
(ura4-D18, ade6-D19, lys3-D20, his5-D21). The right panel shows the diagnostic PCRs to test for the correct upstream (PCR-U) and downstream (PCR-D) integration of the plasmids into
target loci. (B) The PCR-U, PCR-D and PCR-P results performed on transformants at the indicated loci (clones 1-6) and the parental strain (WT) as detailed in (A).
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AV2351
DIC
Actin cytoskeleton (Lifeact)
Figure S2. Aberrant F-actin upon expression of LifeAct-mTagBFP2
Micrographs of cells expressing LifeAct-mTagBFP2, showing aberrant actin cytoskeleton organization.
5µm
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Table S1. List of plasmids used in the study. Please note embedded links to NBRP and Addgene repositories. 
Addgene 
ID NBRP ID 
Plasmid 
ID Plasmid name 
133467 FYP4650 pAV0133 pUra4AfeI 
133468 FYP4651 pAV0356 pAde6PmeI 
133469 FYP4652 pAV0357 pLys3BstZ17I 
133470 FYP4653 pAV0413 pHis5StuI 
133471 FYP4654 pAV0584 pUra4AfeI-natMX 
133472 FYP4655 pAV0585 pAde6PmeI-hphMX 
133473 FYP4656 pAV0586 pLys3BstZ17I-bsdMX 
133474 FYP4657 pAV0587 pHis5StuI-bleMX 
133475 FYP4658 pAV0784 pHis5StuI-bsdMX 
133476 FYP4659 pAV0661 pAde6PmeI-pact1-sfGFP-terminatorScCYC1 
133477 FYP4660 pAV0662 pLys3BstZ17I-pact1-sfGFP-terminatorScCYC1 
133478 FYP4661 pAV0663 pHis5StuI-pact1-sfGFP-terminatorScCYC1 
133479 FYP4662 pAV0714 pUra4AfeI-pact1-sfGFP-terminatorScCYC1 
133480 FYP4663 pAV0746 pUra4AfeI-prga3-sfGFP-terminatorScCYC1 
133481 FYP4664 pAV0747 pUra4AfeI-ppom1-sfGFP-terminatorScCYC1 
133482 FYP4665 pAV0748 pUra4AfeI-ppak1-sfGFP-terminatorScCYC1 
133483 FYP4666 pAV0749 pUra4AfeI-ptdh1-sfGFP-terminatorScCYC1 
133484 FYP4667 pAV0750 pUra4AfeI-purg1-sfGFP-terminatorScCYC1 
133485 FYP4668 pAV0751 pUra4AfeI-pnmt1-sfGFP-terminatorScCYC1 
133486 FYP4669 pAV0752 pUra4AfeI-pnmt41-sfGFP-terminatorScCYC1 
133487 FYP4670 pAV0753 pUra4AfeI-pnmt81-sfGFP-terminatorScCYC1 
133488 FYP4671 pAV0327 pUra4AfeI-pact1-sfGFP-terminatortdh1 
133489 FYP4672 pAV0328 pUra4AfeI-pact1-mCherry-terminatortdh1 
133490 FYP4673 pAV0471 pUra4AfeI-ptdh1*-mTagBFP2-terminatortdh1 
133491 FYP4674 pAV0624 pUra4AfeI-ptdh1-3mTagBFP2-terminatortdh1 
133492 FYP4675 pAV0517 pHis5StuI-pmap3-GFP-terminatornmt 
133493 FYP4676 pAV0543 pLys3BstZ17I-pmap3-mCherry-terminatorScADH1-natMX 
133494 FYP4677 pAV0761 pLys3BstZ17I-pmap3-mTagBFP2-terminatorScADH1-bleMX 
133495 FYP4678 pAV0523 pAde6PmeI-pmam1*-sfGFP-terminatorScADH1-kanMX 
133496 FYP4679 pAV0762 pAde6PmeI-pmam1*-mCherry-terminatorScADH1-kanMX 
133497 FYP4680 pAV0763 pAde6PmeI-pmam1*-mTagBFP2-terminatorScADH1-kanMX 
133498 FYP4681 pAV0478 pHis5StuI-ptdh1-NLSSV40-sfGFP-NLSSV40-natMX 
133499 FYP4682 pAV0479 pHis5StuI-ptdh1-NESwis1-sfGFP-NESmia1-natMX 
133500 FYP4683 pAV0526 pHis5StuI-ptdh1-sfGFP-NLSSV40-natMX 
133501 FYP4684 pAV0765 pLys3BstZ17I-ptdh1-NLSSV40-mCherry-terminatorScADH1-kanMX 
133502 FYP4685 pAV0532 pLys3BstZ17I-ptdh1-NLSSV40-mTagBFP2-terminatortdh1-kanMX 
Continued on the next page 
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Addgene 
ID NBRP ID 
Plasmid 
ID Plasmid name 
133503 FYP4686 pAV0605 pUra4AfeI-pact1-sfGFP-RitC-terminatortdh1 
133504 FYP4687 pAV0607 pAde6PmeI-pact1-mCherry-RitC-terminatorScADH1 
133505 FYP4688 pAV0612 pAde6PmeI-ptdh1-3mTagBFP2-RitC-terminatorScADH1-bsdMX 
133506 FYP4689 pAV0620 pUra4AfeI-ppcn1-eGFP-pcn1-terminatornmt1-natMX 
133507 FYP4690 pAV0785 pUra4AfeI-ppcn1-mCherry-pcn1-terminatornmt1-natMX 
133508 FYP4691 pAV0756 pHis5StuI-pact1-CRIB(gic2aa2-181)-3mCherry-bsdMX 
133509 FYP4692 pAV0757 pHis5StuI-ppak1-CRIB(gic2aa2-181)-3GFP-terminatorScADH1-kanMX 
133510 FYP4693 pAV0816 pAde6PmeI-pact1-CRIB(gic2aa2-181)-mTagBFP2-terminatorScADH1-bsdMX 
133511 FYP4694 pAV0758 pLys3BstZ17I-ppak1-RasAct(3xbyr2RBD)-3GFP-kanMX-terminatorScADH1 
133512 FYP4695 pAV0835 pUra4AfeI-pact1-mCherry-CHDRng2-terminatorScCYC1 
133513 FYP4696 pAV0771 pAde6PmeI-pact1-3mTagBFP2-CHDRng2-terminatorScCYC1 
133514 FYP4697 pAV0782 pAde6PmeI-pact1-LifeAct-sfGFP-terminatorScADH1-bsdMX 
133515 FYP4698 pAV0783 pAde6PmeI-pact1-LifeAct-mCherry-terminatorScADH1-bsdMX 
133516 FYP4699 pAV0772 pAde6PmeI-patb2-sfGFP-atb2-terminatoratb2-hphMX 
133517 FYP4700 pAV0710 pAde6PmeI-patb2-mCherry-atb2-terminatoratb2-hphMX 
133518 FYP4701 pAV0770 pAde6PmeI-patb2-mTagBFP2-atb2-terminatoratb2-hphMX 
133519 FYP4702 pAV0773 pLys3BstZ17I-pBiP-SignalSequenceBiP-sfGFP-AHDL-bsdMX 
133520 FYP4703 pAV0764 pLys3BstZ17I-pBiP-SignalSequenceBiP-mCherry-AHDL-bsdMX 
Not 
deposited 
Not 
deposited pAV0569 pUra4
AfeI-ptdh1*-sfGFP-terminatortdh1 
Not 
deposited 
Not 
deposited pAV0570 pAde6
PmeI-ptdh1*-sfGFP-terminatortdh1 
Not 
deposited 
Not 
deposited pAV0571 pLys3
BstZ17I-ptdh1*-sfGFP-terminatortdh1 
Not 
deposited 
Not 
deposited pAV0572 pHis5
StuI-ptdh1*-sfGFP-terminatortdh1 
Not 
deposited 
Not 
deposited pAV0596 pAde6
PmeI-ura4Casette 
Not 
deposited 
Not 
deposited pAV0597 pLys3
BstZ17I-ura4Casette 
Not 
deposited 
Not 
deposited pAV0598 pHis5
StuI-ura4Casette 
Not 
deposited 
Not 
deposited pAV0616 pAde6
PmeI-ura4casette-hphMX 
Not 
deposited 
Not 
deposited pAV0617 pLys3
BstZ17I-ura4casette-bsdMX 
Not 
deposited 
Not 
deposited pAV0618 pHis5
StuI-ura4casette-bleMX 
Not 
deposited 
Not 
deposited pAV0623 pJK210-natMX 
Not 
deposited 
Not 
deposited pAV0769 pAde6
PmeI-pact1-LifeAct-mTagBFP2-terminatorScADH1-bsdMX 
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Table S2. List of fission yeast strains used in the study. Please note embedded links to NBRP repository. 
NBRP ID ID Genotype Description Source 
FY38487 AV0890 h- ura4+:pact1:sfGFP:terminatortdh1 AV0880 was transformed with AfeI linearized pAV0327 This study 
FY38488 AV0891 h- ura4+:pact1:mCherrry:terminatortdh1 AV0880 was transformed with AfeI linearized pAV0328 This study 
FY38489 AV1196 h+ ura4+:ptdh1*:mTagBFP2:terminatortdh1 AV0879 was transformed with AfeI linearized pAV0471 This study 
FY38490 AV1200 h+ his5+:ptdh1:NLSSV40-sfGFP-NLSSV40:natMX ySM1371 was transformed with StuI linearized pAV0478 This study 
FY38491 AV1201 h+ his5+:ptdh1:NESwis1-sfGFP-NESmia1:natMX ySM1371 was transformed with StuI linearized pAV0479 This study 
FY38492 AV1380 h+ his5+:ptdh1:sfGFP-NLSSV40:natMX AV1139 was transformed with StuI linearized pAV0526 This study 
FY38493 AV1382 h+ his5+:pmap3:GFP:terminatornmt AV1139 was transformed with StuI linearized pAV0517 This study 
FY38494 AV1413 h+ lys3+:pmap3:mCherry:natMX ySM1371 was transformed with SpeI cut pAV0543 This study 
FY38495 AV1469 h- lys3+:ptdh1:NLS-linker-mTagBFP2:terminatortdh1:kanMX ySM995 was transformed with SpeI linearizaed pAV0532 This study 
FY38496 AV1577 h- ura4+:pact1:sfGFP-RitC:terminatortdh1 ade6-M210 AV0729 was transformed with AfeI linearized pAV0605 This study 
FY38497 AV1579 h+ ade6+:pact1:mCherry-RitC:terminatorScADH1 ura4-D18 AV1071 was transformed with PmeI linearized pAV0607 This study 
FY38498 AV1643 h- ade6+:pmam1*:sfGFP:termintorScADH1:kanMX ySM995 was transformed with RsrII/BamHI cut pAV0523 This study 
FY38499 AV1724 h+ ade6+:ptdh1:3mTagBFP2-RitC:terminatorScADH1:bsdMX ySM1371 was transformed with PmeI linearized pAV0612 This study 
FY38500 AV1725 h90 ura4+:ppcn1:eGFP-pcn1:3'UTRpcn1:terminatornmt:natMX ySM1396 was transformed with AfeI linearized pAV0620 This study 
FY38501 AV1769 h- ura4+:ptdh1:3mTagBFP2:terminatortdh1 AV0153 was transformed with AfeI linearized pAV0624 This study 
FY38502 AV2295 h- ade6-D19 basic strain This study 
FY38503 AV2296 h+ ade6-D19 basic strain This study 
FY38504 AV2297 h- ura4-D18 basic strain This study 
FY38505 AV2298 h+ ura4-D18 basic strain This study 
FY38506 AV2300 h- lys3-D20 basic strain This study 
FY38507 AV2301 h+ lys3-D20 basic strain This study 
FY38508 AV2302 h- his5-D21 basic strain This study 
J. Cell Sci.: doi:10.1242/jcs.240754: Supplementary information
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NBRP ID ID Genotype Description Source 
FY38509 AV2303 h+ his5-D21 basic strain This study 
FY38510 AV2319 h- his5+:ppak1:CRIB[gic2aa1-181]-3GFP-terminatorScADH1:kanMX AV2302 was transformed with StuI linearized pAV0757 This study 
FY38511 AV2320 h+ lys3+:ppak1:RasAct-3GFP-terminatorScADH1:kanMX AV2301 was transformed with StuI linearized pAV0758 This study 
FY38512 AV2321 h+ lys3+:pBiP:SignalSequenceBiP-sfGFP-AHDL:bsdMX AV2301 was transformed with StuI linearized pAV0773 This study 
FY38513 AV2322 h+ lys3+:ptdh1:NLS-linker-mCherry:terminatorScADH1:kanMX AV2301 was transformed with StuI linearized pAV0765 This study 
FY38514 AV2323 h+ lys3+:pBiP:SignalSequenceBiP-mCherry-AHDL:bsdMX AV2301 was transformed with StuI linearized pAV0764 This study 
FY38515 AV2324 h- his5+:pact1:CRIB[gic2aa1-181]-3mCherry:bsdMX AV2302 was transformed with StuI linearized pAV0756 This study 
FY38516 AV2327 h+ lys3+:pmap3:mTagBFP2:terminatorScAdh1:bleMX AV2301 was transformed with SpeI linearized pAV0761 This study 
FY38517 AV2349 h- ade6+:pact1:LifeAct-mCherry:terminatorScADH1:bsdMX AV2295 was transformed with RsrII/BlpI fragment of pAV0783 This study 
FY38518 AV2350 h- ade6+:pact1:LifeAct-sfGFP:terminatorScADH1:bsdMX AV2295 was transformed with RsrII/BlpI fragment of pAV0782 This study 
FY38519 AV2353 h- ade6+:pact1:3mTagBFP2-CHDRng2-terminatorScCYC1 AV2295 was transformed with PmeI linearized pAV0771 This study 
FY38520 AV2356 h- ade6+:pmam1*:mCherry:terminatorScADH1:kanMX AV2295 was transformed with RsrII/BlpI fragment of pAV0762 This study 
FY38521 AV2357 h- ade6+:pmam1*:mTagBFP2:terminatorScADH1:kanMX AV2295 was transformed with RsrII/BlpI fragment of pAV0763 This study 
FY38522 AV2362 h90 ura4-D18 basic strain This study 
FY38523 AV2387 h- ade6+:pact1:CRIB[gic2aa1-181]-mTagBFP2:terminatorScADH1:bsdMX AV2343 was transformed with RsrII/BlpI fragment of pAV0816 This study 
FY38524 AV2388 h- ura4+:ppcn1:mCherry-pcn1:3'UTRpcn1:terminatornmt:natMX AV2343 was transformed with AfeI linearized pAV0785 This study 
FY38525 AV2392 h- ade6+:patb2:mCherry-atb2:terminatoratb2:hphMX AV2343 was transformed witth PmeI linearized pAV0710 This study 
FY38526 AV2433 h- ade6+:patb2:mTagBFP2-atb2:terminatoratb2:hphMX AV2343 was transformed witth PmeI linearized pAV0770 This study 
FY38527 AV2434 h- ade6+:patb2:sfGFP-atb2:terminatoratb2:hphMX AV2343 was transformed witth PmeI linearized pAV0772 This study 
FY38528 AV2453 h- ura4+:pact1:mCherry-CHDRng2:terminatorScCYC1 AV0153 was transformed with AfeI linearized pSM2436 This study 
J. Cell Sci.: doi:10.1242/jcs.240754: Supplementary information
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NBRP ID ID Genotype Description Source 
Not deposited ySM995 h- wildtype Fission yeast strain 972 Lab stock 
Not deposited ySM1371 h+ wildtype Fission yeast strain 975 Lab stock 
Not deposited ySM1396 h90 wildtype Fission yeast strain 968 Lab stock 
Not deposited ySM1131 h- pak2∆:ura4+  leu1-32  ura4-D18 Lab stock 
Not deposited AV0138 h90 pak2∆:ura4+ ura4+ Lab stock 
Not deposited AV0226 h+ myo52∆:ura4+ pak2∆:ura4+ ura4+ Lab stock 
Not deposited yMM625 h+ ltc1-sfGFP:kanMX ura4+:pact1:D4H-mCherry Lab stock 
Not deposited yMM1032 h+ ltc1∆:hphMX ura4+:prga3:ltc1-sfGFP ade6+:pact1:mCherry-D4H Lab stock 
Not deposited yMM1036 h+ ltc1∆:hphMX ura4+:ppak1:ltc1-sfGFP ade6+:pact1:mCherry-D4H Lab stock 
Not deposited yMM1034 h+ ltc1∆:hphMX ura4+:ppom1:ltc1-sfGFP ade6+:pact1:mCherry-D4H Lab stock 
Not deposited yMM1015 h+ ltc1∆:hphMX ura4+:pact1:ltc1-sfGFP ade6+:pact1:mCherry-D4H Lab stock 
Not deposited AV2351 Lab stock h- ade6+:pact1:LifeAct-mTagBFP2:terminatorScADH1:bsdMX AV2295 was transformed with RsrII/BlpI fragment of pAV0782 
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Table S3. List of primers used for genotyping. See Figure S1 for usage. 
Serial ID Sequence Tm (°C) 
Length 
(bp) 
GC 
% 
GC 
Clamp 
Secondary 
Structure 
Primer 
Dimer 
Extinction 
Coefficient 
osm236 TCATCATTGTTGGTCGTGGAGTC 68.2 23 47.8 1 None No 216.3 
osm2989 GATTGTACTGAGAGTGCACCAT 60.7 22 45.5 2 Very Weak No 217.6 
osm2991 GTTGATGCCAGACCGTAATGAC 65.4 22 50 1 None No 216.2 
osm2992 CTGTGCGGTATTTCACACCGC 69.6 21 57.1 4 Very Strong No 188.5 
osm4481 GTATGGTTGCTGCAATGAC 59.1 19 47.4 1 Very Weak No 182.7 
osm4536 TTCTGAAGTCCCAAGCACG 64.1 19 52.6 2 None No 179.8 
osm4595 GCCTGGTGCAGTATAAGGTA 59.2 20 50 2 Weak No 201.5 
osm5116 GATAGTACAATTACGCATTCTG 55.6 22 36.4 1 Very Weak No 219.3 
osm5117 CATTTGGTAACCCGCAGTTGG 68.1 21 52.4 2 Very Weak No 197.7 
osm5118 TTGGCTTTGAAGGACGTCGAC 68.5 21 52.4 2 None No 199.2 
osm5119 CCGCATACTGACCAAAAGTGC 66.5 21 52.4 2 Weak No 202.1 
osm6450 CCTGAATAATGTGCTGTGAAGC 63.4 22 45.5 2 Weak No 213.4 
osm6451 TTCTCCTTACGCATCTGTGC 63 20 50 2 Weak No 171.6 
osm6452 TACCTTCCAAACATCGGACAG 63.8 21 47.6 1 Weak No 202.9 
osm6453 TTTCTTGAACATCTTGCTCGTG 64.1 22 40.9 2 None No 195.8 
osm6454 ACATTGGTAAACACTGTAAGTTCG 60.8 24 37.5 2 Very Weak No 241.1 
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Movie 1. Timelapse images of cells expressing indicated fluorophores. Time in hour:min format 
is indicated at the top of each strain.  
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